Antitumorigenic actions of growth hormone-releasing hormone antagonists.
Kineman
R D
RD
University of Illinois, Department of Medicine, Section of Endocrinology and Metabolism, Chicago, IL 60612-7333, USA. kineman@uic.edu
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D018288:Carcinoma, Small Cell / Q000378:metabolism / Q000517:prevention & control; D000242:Cyclic AMP / Q000494:pharmacology; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism / Q000517:prevention & control; D051379:Mice; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors; D018017:Receptors, Pituitary Hormone-Regulating Hormone / Q000037:antagonists & inhibitors; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000187:drug effects; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D018931:Antineoplastic Agents, Hormonal; D018013:Receptors, Neuropeptide; D018017:Receptors, Pituitary Hormone-Regulating Hormone; D014660:Vasoactive Intestinal Peptide; D013007:Growth Hormone-Releasing Hormone; D000242:Cyclic AMP; C048250:somatotropin releasing hormone receptor